share_log

Mirum Pharmaceuticals Q1 2024 GAAP EPS $(0.54) Misses $(0.48) Estimate, Sales $69.222M Miss $70.171M Estimate

Benzinga ·  May 8 16:44

Mirum Pharmaceuticals (NASDAQ:MIRM) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.48) by 12.5 percent. This is a 32.5 percent increase over losses of $(0.80) per share from the same period last year. The company reported quarterly sales of $69.222 million which missed the analyst consensus estimate of $70.171 million by 1.35 percent. This is a 119.07 percent increase over sales of $31.598 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment